Journals / Türkiye Diyabet ve Obezite Dergisi / 2020 / Cilt: 4 - Sayı: 1

Relationship Between First Trimester Screening Test Biomarkers and Gestational Diabetes Mellitus

İlk Trimester Tarama Test Biyobelirteçlerinin Gestasyonel Diyabetes Mellitus İle İlişkisi

Pages
41–45
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, false positive rates for both PAPP-Aand β-hCG are quite high.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Pregnancy-related plasma protein A (PAPP-A) and human chorionic gonadotropin free beta subunit (β-hCG) are used asbiochemical markers in first trimester Down Syndrome screening.
📊
Key Findings & Data:The relationship between gestational diabetes mellitus (GDM) andcombined test results was investigated in this study.Material and Methods: The study group consisted of 95 patients who were diagnosed as GDM and gave birth at our hospital between1 August 2018 and 31 October 2018.
💡
Conclusion & Impact:However, false positive rates for both PAPP-Aand β-hCG are quite high.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Diyabet · gebelik · gebelik ilişkili plazma proteini A

Abstract

Aim: Pregnancy-related plasma protein A (PAPP-A) and human chorionic gonadotropin free beta subunit (β-hCG) are used asbiochemical markers in first trimester Down Syndrome screening. The relationship between gestational diabetes mellitus (GDM) andcombined test results was investigated in this study.Material and Methods: The study group consisted of 95 patients who were diagnosed as GDM and gave birth at our hospital between1 August 2018 and 31 October 2018. The control group consisted of 100 patients who were delivered at term in our hospital, had noadditional disease or pregnancy complications with combined test results. First trimester serum β-hCG and PAPP-A levels of thepatients were compared.Results: PAPP-A level and MoM value and β-hCG level and MoM value were lower in GDM group. (p value 0.013; 0.081; 0.001 and0.007). The optimum cut-off value was 1.715 ng/mL (sensitivity 61%, specificity 22%) for PAPP-A and 0.905 (sensitivity 51.6%, specificity39%) for PAPP-A MoM. The ideal cut-off value was 25.75 mIU/mL (sensitivity 56.8%, specificity 30%) for β-hCG and 0.745 (sensitivity57.9%, specificity 28%) for β-hCG MoM.Conclusion: PAPP-A and β-hCG levels were lower in GDM than healthy pregnant women. However, false positive rates for both PAPP-Aand β-hCG are quite high.

Özet

Amaç: İlk trimester Down Sendromu tarama testi olarak biyokimyasal belirteçler olan gebelik ile ilişkili plazma protein A (PAPP-A) vehuman koriyonik gonadotropin serbest beta alt birimi (β-hCG) kullanılmaktadır. Bu çalışmada gebeliğin ilk üç ayında yapılan kombinetest sonuçlarının gestasyonel diabetes mellitus (GDM) ile ilişkisi araştırılmıştır.Gereç ve Yöntemler: Çalışma grubunu GDM tanısı alan ve doğumu 1 Ağustos 2018 ile 31 Ekim 2018 arasında hastanemizde gerçekleşen95 hasta oluşturmaktaydı. Kontrol grubu için hastanemizde termde doğum yapan, ek hastalığı olmayan, gebelik komplikasyonusaptanmayan ve kombine test sonuçlarına ulaşılabilen 100 hasta rastgele seçilmiştir. Gruplardaki hastaların ilk trimester serum β-hCGve PAPP-A düzeyleri karşılaştırılmıştır.Bulgular: PAPP-A düzeyi ve MoM değeri ile β-hCG düzeyi ve MoM değeri GDM grubunda daha düşük saptanmıştır (sırasıyla, p=0,013,p=0,081, p=0,001 ve p=0,007). En ideal kesme değeri PAPP-A için 1,715 ng/mL (duyarlılık %61 ve özgüllük %22) ve PAPP-A MoMiçin 0,905 (duyarlılık %51,6 ve özgüllük %39) olarak bulundu. En ideal kesme değeri Β-hCG için 25,75 mIU/mL (duyarlılık %56,8 veözgüllük %30) ve β-hCG MoM için 0,745 (duyarlılık %57,9 ve özgüllük %28) olarak bulundu.Sonuç: PAPP-A ve β-hCG düzeyleri GDM gelişenlerde sağlıklı gebelere kıyasla daha düşüktür. Ancak hem PAPP-A hem de β-hCG içinbulunan ideal kesme değerlerde yalancı pozitiflik oranları oldukça yüksektir.

🔖

Cite This Article

ÖRGÜL, G., AYIK, T., ŞAHIN, D., YÜCEL, A. (2022). Relationship Between First Trimester Screening Test Biomarkers and Gestational Diabetes Mellitus. Türkiye Diyabet ve Obezite Dergisi, Cilt: 4 - Sayı: 1, 41–45. https://ajindex.com/articles/627919

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first‐trimester screening for Down's syndrome. Prenat Diagn 1997;17(9):821-9
  2. Ökem ZG, ve ark. Economic analysis of prenatal screening strategies for Down syndrome in singleton pregnancies in Turkey. Eur J Obstet Gynecol Reprod Biol 2017;219:40-4
  3. Donovan BM, ve ark. First trimester prenatal screening biomarkers and gestational diabetes mellitus: A systematic review and meta-analysis. PloS one. 2018;13(7):e0201319
  4. Savvidou M, ve ark. First trimester maternal serum free β‐human chorionic gonadotropin and pregnancy‐associated plasma protein A in pregnancies complicated by diabetes mellitus. BJOG 2012;119(4):410-6
  5. Yaron Y, ve ark. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther 2002;17(6):352-6
  6. Ferrara A. Increasing prevalence of gestational diabetes mellitus: a public health perspective. Diabetes care 2007;30(Supplement 2):141-6
  7. Ayhan S, ve ark. Prognosis of Pregnancies with Different Degrees of Glucose Intolerance. Gynecology Obstetrics & Reproductive Medicine. 2016;19(2)
  8. Dugoff L, ve ark. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191(4):1446-51
  9. Husslein H, ve ark. Association between pregnancy-associated plasma protein-A and gestational diabetes requiring insulin treatment at 11–14 weeks of gestation. J Matern Fetal Neonatal Med 2012;25(11):2230-3
  10. Tul N, ve ark. Predicting complications of pregnancy with first‐trimester maternal serum free‐βhCG, PAPP‐A and inhibin‐A. Prenat Diagn 2003;23(12):990-6
  11. Shiefa S, ve ark. First trimester maternal serum screening using biochemical markers PAPP-A and free β-hCG for down syndrome, patau syndrome and edward syndrome. Indian J Clin Biochem 2013;28(1):3-12
  12. Theofanakis C, ve ark. Human chorionic gonadotropin: the pregnancy hormone and more. Int J Mol Sci 2017;18(5):1059
  13. TC Sağlık Bakanlığı, Turkish Public Health Instutition, Department of Women's Reproductive Health). Doğum Öncesi Bakım Yönetim Rehberi (Antenatal Care Management Guideline). Ankara: 2014
  14. Irwin J, ve ark. Role of the IGF system in trophoblast invasion and pre-eclampsia. Hum reprod 1999;14(suppl_2):90-8
  15. Spencer K, Cowans NJ. The association between